| Revenue | 31/01/2019 | 31/01/2018 | 31/01/2017 | 31/01/2016 |
| Total revenue | 44 | - | - | - |
| Cost of revenue | - | - | - | - |
| Gross profit | 44 | - | - | - |
| Operating expenses |
| Research development | 3,673 | 5,019 | 10,911 | 9,965 |
| Selling general and administrative | 1,466 | 1,739 | 2,062 | 1,590 |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 5,139 | 6,758 | 12,973 | 11,555 |
| Operating income or loss | -5,095 | -6,758 | -12,973 | -11,555 |
| Income from continuing operations |
| Total other income/expenses net | 10 | 39 | -3,225 | 271 |
| Earnings before interest and taxes | -5,095 | -6,758 | -12,973 | -11,555 |
| Interest expense | - | - | - | - |
| Income before tax | -5,085 | -6,719 | -16,198 | -11,284 |
| Income tax expense | -1,086 | -1,360 | -3,073 | -2,464 |
| Minority interest | - | - | - | - |
| Net income from continuing ops | -3,999 | -5,359 | -13,125 | -8,820 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | -3,999 | -5,359 | -13,125 | -8,820 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | -3,999 | -5,359 | -13,125 | -8,820 |